Chronisch Lymphatische Leukämie Guidline and Quality indicator
0.2.0 - ci-build

Chronisch Lymphatische Leukämie Guidline and Quality indicator - Local Development build (v0.2.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

CodeSystem: CLL_V2

Official URL: https://www.medizin.uni-greifswald.de/fhir/guideline/cll/CodeSystem/cll-v2 Version:
Draft as of 2025-01-16 Computable Name: CLL_V2

Concepts required in recommendations that are not defined elsewhere

This Code system is referenced in the content logical definition of the following value sets:

  • This CodeSystem is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Generated Narrative: CodeSystem cll-v2

This code system https://www.medizin.uni-greifswald.de/fhir/guideline/cll/CodeSystem/cll-v2 defines the following codes:

CodeDisplay
dprnt Disease progression that requires adapted or new treatment
dprnti Disease progression that requires adapted or new treatment with idelalisib
scllt Systemic CLL therapy
porecotr Poor response to corticosteroid treatment
sycasp Symptom-causing splenomegaly
cllrete CLL Relapse therapy
ingrfiftyintwomo Zunahme mehr als 50 Prozent innerhalb von 2 Monaten, gemessen ab einer absoluten Lymphozytenzahl von mindestens 30.000/µl
dopeunsixmo Lymphozytenverdopplungszeit unter 6 Monaten, gemessen ab einer absoluten Lymphozytenzahl von mindestens 30.000/µl
cllflt CLL-specific firstline treatment
cllrlpstherapy CLL-relapse under treatment
cllrlpsincl Inclusion into specific CLL relapse treatment study